Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care

Xavier Mundet-Tudurí, Manuel Iglesias-Rodal, Carmen Olmos-Domínguez, M. Lluïsa Bernard-Antoranz, M. Isabel Fernández-San Martín, Ester Amado-Guirado

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


Aim. To compare the prevalence of cardiovascular risk factors (CVRF) and vascular events, between patients treated and untreated with antipsychotic drugs. Subjects and methods. A cross-sectional study was done in Barcelona. We compared patients attended in Primary Health Care Centres, treated with or without antipsychotics between 2008 and 2010. Anthropometric measurements, clinical variables, and CVRF were assessed. Adult and elderly patients, typical and atypical antipsychotics, were studied separately. Results. 14,087 patients had been prescribed antipsychotics (63.4% atypical), the most common being risperidone. We selected 13,724 patients with the same age and gender but not treated (total of 27,811 patients). Patients receiving antipsychotic had higher prevalence of obesity (16.9% vs. 11.9%), smoking (22.2% vs. 11.1%), diabetes mellitus (16% vs. 11.9%), and dyslipidemia (32.8% vs. 25.8%) (p < 0.001). The prevalence of stroke was significantly higher in the treated patients, both in adults (odds ratio = 2.33) and the elderly (odds ratio = 1.64). The prevalence of coronary heart disease was similar in both groups (odds ratio = 0.97). Among patients treated with antipsychotic, differences were not observed depending typical or atypical ones. Conclusions. Patients treated with antipsychotic drugs had a greater prevalence of several CVRF (diabetes mellitus, obesity, and smoking). The presence of stroke was higher in those treated with antipsychotics. No relevant differences were observed between patients receiving typical or atypical antipsychotics. © 2013 Revista de Neurología.
Original languageEnglish
Pages (from-to)495-503
JournalRevista de Neurologia
Issue number11
Publication statusPublished - 11 Dec 2013


  • After treatment
  • Antipsychotic agents
  • Antipsychotic effect
  • Cardiovascular disease
  • Cerebrovascular disorder
  • Primary care


Dive into the research topics of 'Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care'. Together they form a unique fingerprint.

Cite this